National Guideline Clearinghouse | 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

full-text ►

National Guideline Clearinghouse | 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.



American College of Cardiology Foundation

Guideline Title

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Bibliographic Source(s)

Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith SC Jr, Watson K, Wilson PW. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014 Jul 1;63(25 Pt B):2889-934. [144 references] PubMed

Guideline Status

This is the current release of the guideline.

This guideline meets NGC's 2013 (revised) inclusion criteria.

.-.-.

2013 ACC/AHA guideline on the treatment of blood cholesterol to red... - PubMed - NCBI

J Am Coll Cardiol. 2014 Jul 1;63(25 Pt B):2889-934. doi: 10.1016/j.jacc.2013.11.002. Epub 2013 Nov 12.

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS,Shero ST, Smith SC Jr, Watson K, Wilson PW; American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Erratum in

• J Am Coll Cardiol. 2014 Jul 1;63(25 Pt B):3024-3025.

KEYWORDS:

ACC/AHA Practice Guideline; biomarkers, pharmacological; cardiovascular disease; cholesterol; diabetes mellitus; drug therapy; hydroxymethylglutaryl-CoA reductase inhibitors/statins; hypercholesterolemia; lipids; patient compliance; primary prevention; risk assessment; risk reduction behavior; secondary prevention

Comment in

• Reply: is myopathy the achilles' heel of statins?: differences between the new cholesterol treatment guidelines and everyday clinical practice. [J Am Coll Cardiol. 2014]
• Measurement of low-density lipoprotein cholesterol in assessment and management of cardiovascular disease risk. [Clin Pharmacol Ther. 2014]
• 2013 ACC/AHA Guideline: a guideline for the population - without evidence from the population. [Cardiovasc Drugs Ther. 2014]
• Is myopathy the Achilles' heel of statins?: differences between the new cholesterol treatment guidelines and everyday clinical practice. [J Am Coll Cardiol. 2014]

PMID:

 

24239923

 

[PubMed - indexed for MEDLINE] 

Free full text